Whittier Trust Co. Raises Holdings in Kenvue Inc. $KVUE

Whittier Trust Co. increased its position in Kenvue Inc. (NYSE:KVUE) by 5.6% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 16,325 shares of the company’s stock after buying an additional 871 shares during the period. Whittier Trust Co.’s holdings in Kenvue were worth $342,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in KVUE. Vanguard Group Inc. raised its position in shares of Kenvue by 4.9% in the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock worth $5,494,882,000 after buying an additional 10,600,682 shares during the period. Third Point LLC purchased a new position in shares of Kenvue in the 1st quarter worth $213,422,000. Maverick Capital Ltd. purchased a new position in shares of Kenvue in the 1st quarter worth $203,036,000. Nuveen LLC purchased a new position in shares of Kenvue in the 1st quarter worth $187,123,000. Finally, Voya Investment Management LLC raised its position in shares of Kenvue by 131.3% in the 1st quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company’s stock worth $290,557,000 after buying an additional 6,886,784 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

KVUE has been the topic of several research reports. Canaccord Genuity Group cut their target price on Kenvue from $29.00 to $26.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Zacks Research raised Kenvue to a “strong sell” rating in a research report on Monday, August 11th. The Goldman Sachs Group cut their price objective on Kenvue from $22.00 to $19.00 and set a “neutral” rating on the stock in a research report on Thursday, October 2nd. Bank of America cut their price objective on Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada cut their price objective on Kenvue from $24.00 to $22.00 and set a “sector perform” rating on the stock in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $21.18.

Kenvue Stock Down 0.8%

Shares of NYSE KVUE opened at $15.07 on Friday. Kenvue Inc. has a 1 year low of $14.05 and a 1 year high of $25.17. The firm has a market cap of $28.91 billion, a price-to-earnings ratio of 20.36, a PEG ratio of 2.19 and a beta of 0.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The stock’s 50-day simple moving average is $18.03 and its 200-day simple moving average is $20.84.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period in the previous year, the company earned $0.32 earnings per share. The company’s revenue for the quarter was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.5%. Kenvue’s dividend payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.